EUVIMEDEUVIMED entdecken
Crossref

Pembrolizumab in the non-small-cell lung cancer patients – reasons to consider its use

Magdalena Knetki-Wróblewska

OncoReview · 2017

DOI: 10.24292/01.or.141217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoReview, 2017. Verfasst von Magdalena Knetki-Wróblewska.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Knetki-Wróblewska, M. (2017). Pembrolizumab in the non-small-cell lung cancer patients – reasons to consider its use. OncoReview. https://doi.org/10.24292/01.or.141217

Vancouver

Knetki-Wróblewska M. Pembrolizumab in the non-small-cell lung cancer patients – reasons to consider its use. OncoReview. 2017. doi:10.24292/01.or.141217

BibTeX
@article{KnetkiWrblewska2017,
  author = {Knetki-Wróblewska, Magdalena},
  title = {Pembrolizumab in the non-small-cell lung cancer patients – reasons to consider its use},
  journal = {OncoReview},
  year = {2017},
  doi = {10.24292/01.or.141217}
}
Kostenlos starten →